Suping ZHANG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation (NCT06339775) | Suping ZHANG | 2023-09-01 |
Track Suping ZHANG automatically
Every clearance here is in the API, with alerts when new ones post.